Approval · Notice of Compliance 28070 · 2022
MARCAINE E: Notice of Compliance 28070
Issued May 2, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28070
- Date
- May 2, 2022
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to Labels.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MARCAINE E | Not yet assigned | — |
Medicinal ingredients
- BUPIVACAINE HYDROCHLORIDE 2.5 MG per ML
- EPINEPHRINE BITARTRATE 9.1 MCG per ML
- BUPIVACAINE HYDROCHLORIDE 5 MG per ML